United States · FDA National Drug Code directory

RANOLAZINE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2556_034cad2b-aaf4-457c-ae88-ab785ad4ac18
Product NDC
71335-2556
Form
TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term
RANOLAZINE
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20220615
Source listing expiry
20261231

Source-listed ingredients

  • RANOLAZINE — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-2556-1) · 71335-2556-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →